The new male contraception method is an alternative to traditional sterilisation by surgery which 2-5 million men (procedure called vasectomy) and 6-10 million women (procedure called tubal ligation) in developed regions undergo yearly.
The solution will be marketed as a medical device and offers the big advantage that fertility may quite easily be restablished.
The solution has patent pending.
The company is right now in a phase where the focus is on developing prototypes and conduct in-vivo testing to prove the concept. In this regard, VasDeBlock medical ApS is looking for financing from sources willing to contribute to the next steps. Financing may be in the form of grants, loans or direct investment in the company.
We thank Låneforeningen af tjenestemænd i Københavns Kommune for their donations.
Make a donation